Pliant Therapeutics Inc Cash Flow Quality Index

Latest as of March 2020: -1.16x

Pliant Therapeutics Inc cash flow quality index. Pliant Therapeutics Inc (PLRX) has a Cash Flow Quality Index of -1.16x as of March 2020. Operating cash flow of $-12.77 Million is below net income of $11.03 Million, suggesting accrual-heavy earnings not yet converted to cash. See PLRX FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

-1.16x

Operating CF / Net Income

Operating Cash Flow

$-12.77 Million

USD

Net Income

$11.03 Million

USD

Data as of

Mar 2020

Most recent filing

Pliant Therapeutics Inc Cash Flow Quality Index by Year (None–None)

Pliant Therapeutics Inc cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Pliant Therapeutics Inc. For the full cash flow conversion analysis, see Pliant Therapeutics Inc (PLRX) cash conversion ratio.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.